title: Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.
authors.affiliation: University of Florida, Gainesville, FL; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Carmen J
authors.initials: CJ
authors.lastname: Allegra
authors.affiliation: University of Florida, Gainesville, FL; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: R Bryan
authors.initials: RB
authors.lastname: Rumble
authors.affiliation: University of Florida, Gainesville, FL; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Richard L
authors.initials: RL
authors.lastname: Schilsky
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D004252:DNA Mutational Analysis; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D011905:Genes, ras; D005820:Genetic Testing; D006801:Humans; D009154:Mutation; D011379:Prognosis
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D066246:ErbB Receptors